<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Non-coding <z:chebi fb="40" ids="33697">RNAs</z:chebi> have critical functions in diverse biological processes, particularly in gene regulation </plain></SENT>
<SENT sid="1" pm="."><plain>Viruses, like their host cells, employ such functional <z:chebi fb="40" ids="33697">RNAs</z:chebi> and the human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> associated Epstein-Barr virus (EBV) is no exception </plain></SENT>
<SENT sid="2" pm="."><plain>Nearly <z:hpo ids='HP_0000001'>all</z:hpo> EBV associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> express the EBV small, non-coding <z:chebi fb="40" ids="33697">RNAs</z:chebi> (EBERs) 1 and 2, however their role in <z:mp ids='MP_0001799'>viral</z:mp> pathogenesis remains largely obscure </plain></SENT>
<SENT sid="3" pm="."><plain>METHODOLOGY/PRINCIPAL FINDINGS: To investigate the action of EBER1 in vivo, we produced ten transgenic mouse lines expressing EBER1 in the lymphoid compartment using the mouse immunoglobulin heavy chain intronic enhancer Emicro </plain></SENT>
<SENT sid="4" pm="."><plain>Mice of several of these EmicroEBER1 lines developed <z:mp ids='MP_0000688'>lymphoid hyperplasia</z:mp> which in some cases proceeded to B cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The hallmark of the transgenic phenotype is enlargement of the spleen and mesenteric lymph nodes and in some cases enlargement of the thymus, liver and peripheral lymph nodes </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> were found to be of B cell origin and showed clonal IgH rearrangements </plain></SENT>
<SENT sid="7" pm="."><plain>In order to explore if EBER1 would cooperate with c-Myc (deregulated in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) to accelerate <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e>, a cross-breeding study was undertaken with EmicroEBER1 and EmicroMyc mice </plain></SENT>
<SENT sid="8" pm="."><plain>While no significant reduction in latency to <z:hpo ids='HP_0002665'>lymphoma</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> was observed in bi-transgenic mice, c-Myc induction was detected in some EmuEBER1 single transgenic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, indicative of a functional cooperation </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/SIGNIFICANCE: This study is the first to describe the in vivo expression of a polymerase III, non-coding <z:mp ids='MP_0001799'>viral</z:mp> gene and demonstrate its oncogenic potential </plain></SENT>
<SENT sid="10" pm="."><plain>The data suggest that EBER1 plays an oncogenic role in EBV associated malignant disease </plain></SENT>
</text></document>